Toggle light / dark theme

Charlotte Trainer thought she was out of options when she was diagnosed with Stage-4 inoperable Endometrial cancer in November of 2017. After having a full hysterectomy and 25 rounds of radiation, her doctors told her that the cancer had metastasized to her lungs. There was nothing else they could offer her.

Today, she celebrates being cancer free for one full year after being treated at CHIPSA hospital.

More broadly, biologists are wondering how else deep learning — the AI technique used by both approaches — might be applied to the prediction of protein arrangements, which ultimately dictate a protein’s function. These approaches are cheaper and faster than existing lab techniques such as X-ray crystallography, and the knowledge could help researchers to better understand diseases and design drugs. “There’s a lot of excitement about where things might go now,” says John Moult, a biologist at the University of Maryland in College Park and the founder of the biennial competition, called Critical Assessment of protein Structure Prediction (CASP), where teams are challenged to design computer programs that predict protein structures from sequences.


Deep learning makes its mark on protein-structure prediction.

Millions of people who take aspirin to prevent a heart attack may need to rethink the pill-popping, Harvard researchers reported Monday.

A daily low-dose aspirin is recommended for people who have already had a heart attack or stroke and for those diagnosed with heart disease.

But for the otherwise healthy, that advice has been overturned. Guidelines released this year ruled out routine aspirin use for many older adults who don’t already have heart disease — and said it’s only for certain younger people under doctor’s orders.

Fifty years after the Apollo 11 lunar landing proved that America could meet President John F. Kennedy’s challenge and beat Russia in the space race, man is walking on the moon once again. This time inside a Lunar Dome at the Rose Bowl.

“Apollo 11 — The Immersive Live Show,” which is in previews and officially opens Wednesday, promises a multimedia spectacle under a gigantic $5-million dome designed to tell a big story in a big way: with live actors, documentary footage, archival audio, 360-degree video projection and props that will simulate a rocket launch and include a life-size re-creation of the lunar landing module. Yes, the one with funny foil hanging around it.

The project is the brainchild of British producer Nick Grace, veteran of international tours of the musical “Mamma Mia!” and Blue Man Group. (Grace’s production is also at the center of an L.A. Times Ideas Exchange program on July 20.)

Whether or not creating an AGI is even possible remains up for debate. Meanwhile, others may cringe at the thought of an AI with the intellect to match and exceed humanity. However, OpenAI has been bullish on the prospect. The company points to the breakthroughs researchers have made in last decade in getting AI algorithms to recognize images, translate languages, and control robots. One of OpenAI’s own AI projects can write fiction like a human can (sort of).

However, creating new AI-based technologies costs a lot of money. Not only does it require programming, but also renting access to thousands of servers. So OpenAI has been seeking funding. “The most obvious way to cover costs is to build a product, but that would mean changing our focus. Instead, we intend to license some of our pre-AGI technologies, with Microsoft becoming our preferred partner for commercializing them,” Altman wrote in a separate blog post.

  • The AI Breakthrough Will Require Researchers Burying Their Hatchets.